Dermcidin exerts its oncogenic effects in breast cancer via modulation of ERBB signalingJasna Bancovik, José Ernesto Belizário, Dale Porter et al.|BMC Cancer|2015Cited by 34
Potentiation of combined p19Arf and interferon-beta cancer gene therapy through its association with doxorubicin chemotherapyRuan F.V. Medrano, Bryan E. Strauss|Scientific Reports|2022Cited by 6